Abstract:634 Background: Prognosis following surgery for pancreatic cancer (PC) remains poor. Local recurrence is common and negatively impacts survival rate. In an effort to improve local control and potentially improve survival, we have adopted a strategy of adding intra-operative electron radiation therapy (IOeRT) to selected patients undergoing pancreatic resection (PR) for PC. Here we report our initial experience with this treatment modality. Methods: 14 patients (10 male, 4 female), age between 44 - 81 years (mean 66.17), who underwent PR (Head 7, Body7) between 1/2021-1/2023 were included in this analysis. Patients selected for IOeRT included patients that according to surgeon assessment were at risk not to achieve satisfactory resection margins by surgery alone. All had resectable or borderline resectable disease according to standard criteria. 8 patients underwent pre-op chemotherapy followed by stereotactic body radiotherapy (SBRT) to a dose of 25-40 Gy in 5 fractions to the tumor and regional lymphatics followed by PR (5 Whipple, 3 distal pancreatectomy) and IOeRT, 3 patients received preop SBRT followed by PR (3 distal pancreatectomy) + IOeRT, 2 patients underwent PR (whipple 1, distal pancreatectomy 1) + IoeRT, and 1 received neoadjuvant chemotherapy followed by SBRT only and did not undergo surgery due to tumor progression. Immediately following resection, mobile IOeRT accelerator using a 40-80mm applicator with a level of 0-15 degrees was directed at the tumor bed deemed at high risk for recurrence. 10-20 Gy was delivered using 6-8 MeV electrons to the 90% isodose line at the discretion of the treating radiation oncologist. Data including serial imaging, genomic analysis, radiation protocol, complications, pathological results and outcome was collected for analysis. Results: Mean follow up was 9.7 months (2-21). 8 patients are alive: 7 pts with no evidence of disease and 1 pt with liver metastases. 6 patients died: 4 with distant metastatic disease, 1 from disease progression prior to surgery and 1 from early post-op sepsis. Negative surgical margins were achieved in 10 patients of which 2 mutated BRCA gene carriers showed complete pathological response (both who received combined neoadjuvant chemotherapy followed by SBRT). Post-operative complications possibly attributed to RT included hepatic artery occlusion (1 pt), portal vein stenosis (1 pt) and prolonged GI tract dysfunction (1pt). Conclusions: Combining RT with resection appears feasible and safe. Our data possibly show a reduction in local recurrence following resection of PC, however, longer follow up is necessary. Refinements in patient selection and treatment protocol may further improve outcomes. Larger scale studies are required to determine the benefit of this modality.

Value of Intraoperative Radiotherapy in the Treatment of Locally Advanced Pancreatic Cancer

Intraoperative radiotherapy vs concurrent chemoradiotherapy in the treatment of patients with locally advanced pancreatic cancer

IORT and Regional Chemotherapy in Patients with Locally Advanced Pancreatic Carcinoma

Intraoperative Radiotherapy for 42 Patients with Advanced Pancreatic Carcinoma

Intraoperative Radiotherapy for Borderline Resectable Pancreatic Cancer: A Retrospective Analysis

Intraoperative radiotherapy using a mobile linear acceletator for locally advanced pancreatic cancer

Effect of Intraoperative Radiotherapy Combined with External Beam Radiotherapy Following Internal Drainage for Advanced Pancreatic Carcinoma.

Long-term Results of Intraoperative Electron Beam Radiation Therapy for Nonmetastatic Locally Advanced Pancreatic Cancer

Long-term Outcomes and Prognostic Factors for Locally-Advanced Pancreatic Cancer Patients Treated with Intraoperative Radiation Therapy

Organ Preserving Strategies is an Alternative for the Management of Pediatric Patients with Solid Pseudopapillary Neoplasm.

Intraoperative Radiotherapy in the Combination of Adjuvant Chemotherapy for the Treatment of Pt3n0m0 Rectal Cancer after Radical Surgery

[Intraoperative 125I Brachytherapy Combined with Chemotherapy for Pancreatic Cancer].

Intra-operative radiation for pancreatic cancer: Initial experience at the Hadassah Medical Center.

Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.

Intraoperative radiotherapy in gastric and esophageal cancer: meta-analysis of long-term outcomes and complications.

Adjuvant Chemoradiation Plus Intraoperative Radiotherapy Versus Adjuvant Chemoradiation Alone in Patients with Locally Advanced Rectal Cancer

Improved Survival in Patients with Resected Pancreatic Carcinoma Using Postoperative Intensity-Modulated Radiotherapy and Regional Intra-Arterial Infusion Chemotherapy

Retrospective study on laparoscopic surgery combined with intraoperative radiotherapy in treatment of locally advanced rectal cancerc

Intensity Modulated Radiation Therapy and Chemotherapy for Locally Advanced Pancreatic Cancer: Results of Feasibility Study

A safety study of intraoperative radiation therapy following stereotactic body radiation therapy and multi-agent chemotherapy in the treatment of localized pancreatic adenocarcinoma: study protocol of a phase I trial